Morpholino

MO1-jagn1b

ID
ZDB-MRPHLNO-250204-2
Name
MO1-jagn1b
Previous Names
None
Target
Sequence
5' - CATGGCAAACCACCTCCGTCGACAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-jagn1b
No data available
Phenotype
Phenotype resulting from MO1-jagn1b
Phenotype of all Fish created by or utilizing MO1-jagn1b
Phenotype Fish Conditions Figures
caudal fin neutrophil GFP expression decreased amount, abnormal i114Tg/i114Tg + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
caudal fin neutrophil decreased amount, abnormal i114Tg/i114Tg + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
whole organism ddit3 expression increased amount, abnormal TU + MO1-jagn1b chemical treatment by environment: tunicamycin Fig. 4 with image from Doll et al., 2024
caudal fin neutrophil lyz expression decreased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 4 with image,  Fig. 5 with image,  Fig. 6 with image from Doll et al., 2024
whole organism cebpb expression increased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
caudal fin neutrophil lyz expression decreased amount, abnormal TU + MO1-jagn1b chemical treatment by environment: 1,4-dithiothreitol Fig. 4 with image from Doll et al., 2024
whole organism ddit3 expression increased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 4 with image from Doll et al., 2024
whole organism ddit3 expression increased amount, abnormal TU + MO1-jagn1b chemical treatment by environment: 1,4-dithiothreitol Fig. 4 with image from Doll et al., 2024
caudal fin apoptotic process increased occurrence, exacerbated TU + MO1-jagn1b chemical treatment by environment: staurosporine Fig. 5 with image from Doll et al., 2024
whole organism csf3a expression increased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
neutrophil lyz expression decreased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 2 with image from Doll et al., 2024
whole organism xbp1 expression increased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 4 with image from Doll et al., 2024
caudal fin neutrophil lyz expression decreased amount, abnormal TU + MO1-jagn1b chemical treatment by environment: tunicamycin Fig. 4 with image from Doll et al., 2024
whole organism cebpa expression increased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
caudal fin neutrophil lyz expression decreased amount, abnormal TU + MO1-jagn1b chemical treatment by environment: staurosporine Fig. 5 with image from Doll et al., 2024
whole organism ppp1r15a expression decreased amount, abnormal TU + MO1-jagn1b standard conditions Fig. 4 with image from Doll et al., 2024
caudal fin apoptotic process increased occurrence, abnormal TU + MO1-jagn1b standard conditions Fig. 5 with image from Doll et al., 2024
caudal fin neutrophil GFP expression decreased amount, abnormal i114Tg/i114Tg + MO1-cebpb + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
caudal fin neutrophil decreased amount, exacerbated i114Tg/i114Tg + MO1-cebpb + MO1-jagn1b standard conditions Fig. 6 with image from Doll et al., 2024
Citations